Factor XIII: Structure, activation, and interactions with fibrinogen and fibrin

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 291-311

  Lorand, Laszlo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Activation; Factor XIII; Fibrin stabilization; Fibrinogen; Interactions; Structure

Indexed keywords

BLOOD CLOTTING FACTOR 8; ENZYME PRECURSOR; FIBRIN; FIBRINOGEN;

AMINO TERMINAL SEQUENCE; CONFERENCE PAPER; COVALENT BOND; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVATION; HUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REACTION ANALYSIS; REGULATORY MECHANISM; STRUCTURE ANALYSIS; VISCOELASTICITY;

EID: 0034972479     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03516.x     Document Type: Conference Paper

References (94)

1. Sol Sherry lecture in thrombosis. Research on clot stabilization provides clues for improving thrombolytic therapies
2. A study on the solubility of fibrin clots in urea
3. Untersuchungen über die einwirkung hydrotroper substanzen auf das fibrinogen und die blutgerinnung
4. Ueber lösung und fällung von eiweisskörpern durch salze. Hoppe-Seyler's zeit
5. Ueber die beeinflussung der eiweisscoagulation durch stickstoffhaltige substanzen. Hoppe-Seyler's zeit
6. The action of thrombin on fibrinogen
7. "Fibrino-peptide": New aspects of the fibrinogen-fibrin transformation
8. Fibrino-peptide
9. On the solubility of fibrin clots
10. A study on the conversion of fibrinogen to fibrin
11. Solubility of fibrin clots in monochloroacetic acid. A reflection of serum pepsinogen levels
12. Fibrin clots
13. On the primary structure of human fibrinogen. I. Two-dimensional "finger prints" of tryptic digests of sulfitolyzed fibrinogen and fibrin
14. Activation of the fibrin stabilizing factor of plasma by thrombin
15. Amine specificity in transpeptidation. Inhibition of fibrin crosslinking
16. Transglutaminase as a blood clotting enzyme
17. The transpeptidase system which crosslinks fibrin by γ-glutamyl-ε-lysine bonds
18. The identification of isopeptide crosslinks in insoluble fibrin
19. Crosslink in fibrin polymerized by factor XIII: ε(γ-glutamyl)lysine
20. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor
21. a) and for transglutaminase. Transfer of the fluorescently labeled acyl group to amines and alcohols
22. Role of histidine 373 in the catalytic activity of coagulation factor XIII
23. A new class of blood coagulation inhibitors
24. Transamidase reactions involved in the enzymic coagulation of semen: Isolation of γ-glutamyl-ε-lysine dipeptide from clotted secretion protein of guinea pig seminal vesicle
25. Cross-linked Aα-γ chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase
26. Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase
27. Specificity of guinea pig liver transglutaminase for amine substrates
28. Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase
29. Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines
30. Transglutaminases
31. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and crosslinking of fibrinogen and fibrin
32. Structure of transglutaminases
33. Factor XIII (fibrin stabilizing factor)
34. Amino acid sequence of the a subunit of human factor XIII
35. A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases
36. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules
37. Three-dimensional structure of a transglutaminase: Human blood coagulation factor XIII
38. 2+-related regulatory function of fibrinogen
39. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin
40. Association of the A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma
41. Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen
42. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII
43. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen
44. Regulation of the formation of factor XIIIa by its fibrin substrates
45. Human factor XIII: Fibrin stabilizing factor
46. Studies on the polymerization of fibrin. The role of the globulin: Fibrin-stabilizing factor
47. Properties and significance of the fibrin stabilizing factor (FSF)
48. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen
49. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains
50. Interactions of human fibrinogens with factor XIII: Roles of calcium and the γ′ peptide
51. The role of γA/γ′ fibrinogen in plasma factor XIII activation
52. Intramolecular localization of the acceptor crosslinking sites in fibrin
53. Titration of the acceptor crosslinking sites in fibrin
54. Interactions of factor XIII with fibrin as substrate and cofactor
55. Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation
56. Fibrinoligase. The stabilizing factor system of blood plasma
57. The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E
58. a
59. A double-headed GlyProArgPro ligand mimics the function of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by Factor XIIIa
60. Structural origins of fibrin clot rheology
61. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen
62. Accelerated lysis of blood clots
63. Inhibitor of fibrin crosslinking: Relevance for thrombolysis
64. Molecular approach for designing inhibitors to enzymes involved in blood clotting
65. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and hemostasis
66. 2-plasmin inhibitor to fibrin
67. γ-γ Cross-linking sites in human and bovine fibrin
68. Subunit structure of human fibrinogen, soluble fibrin and crosslinked insoluble fibrin
69. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin
70. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular function
71. Labeling of ε-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase
72. Biotinylated peptides containing a factor XIIIa or tissue transglutaminase-reactive glutaminyl residue block protein cross-linking phenomena by becoming incorporated into amine donor sites
73. Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at crosslinked sites of the γ-chain. Sequence of carboxy-terminal cyanogen bromide γ-chain fragments
74. Amino acid sequence studies on the α chain of human fibrinogen. Exact location of cross-linking acceptor sites
75. Localization of the α-chain cross-link acceptor sites of human fibrin
76. Identification of ε-lysine cross-linking sites in the α chains of fibrin and the tissue transglutaminase carrying role of fibronectin in plasma
77. Identification of the α chain lysine donor sites involved in factor XIIIa fibrin cross-linking
78. Factor XIIIa-catalyzed cross-linking of recombinant αC fragments of human fibrinogen
79. 2-plasmin inhibitor
80. 2-antiplasmin to fibrin(ogen)
81. 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase
82. Transglutaminase-catalyzed crosslinking of the Aα and γ constituent chains in fibrinogen
83. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency
84. A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenemia
85. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation
86. Inheritance of deficiency of fibrin-stabilizing factor (factor XIII)
87. Four novel mutations in deficiency of coagulation factor XIII: Consequences to expression and structure of the A-subunit
88. Type 1 factor XIII deficiency is caused by a genetic defect of its b subunit: Insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain
89. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity
90. Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity
91. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
92. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction
93. Factor XIII Val34Leu: A novel association with primary intracerebral hemorrhage
94. Acquired inhibitors of fibrin stabilization: A class of hemorrhagic disorders of diverse origins